+65 65881289
contact@bilpublishing.com
ISSN: 2630-5267(Online) Email:jor@bilpublishing.com | Journal of Oncology Research publishes papers that offer a rapid review and publication that freely disseminates research findings in the area of Oncology including Carcinogenesis, Metastasis, Cancer Prevention, Cancer Chemotherapy and more. The Journal focuses on innovations of research methods at all stages and is committed to providing theoretical and practical experience for all those who are involved in these fields. Journal of Oncology Research aims to discover innovative methods, theories and studies in Oncology by publishing original articles, case studies and comprehensive reviews. The scope of the papers in this journal includes, but is not limited to:
|
Submission Preparation Checklist
By submitting a manuscript to the journal, the Author(s) verifies that the following items have been met:
- The submission has not been previously published under another journal, or is currently under consideration for another journal.
- The submission format should be in Microsoft Word. Other word processing software may be considered.
- DOIs or URLs have been provided wherever possible in the Reference List.
- The document(s) have been formatted according to the requirements under Author Guidelines. The placement of illustrations, figures, graphs, tables, and equations have been integrated into the main manuscript.
- Instructions in Ensuring a Blind Review have been followed in order to comply with the double-blind peer review process employed.
Vol 3, No 2 (2021)
Full Issue
| View or download the full issue |
Table of Contents
Articles
|
Yunbo Zhang, Liping Zheng, Junqi Liu, Jinqiu Li, Jianguang Zhang, Jingjing Ma, Yuxiu Song Views - 57 (Abstract) Abstract:The purpose of this study is to clarify the significance of postoperative radiotherapy for N2 lung cancer. This study aimed to investigate the effect of postoperative radiotherapy on the survival and prognosis of patients with N2 lung cancer. Data from 12,000 patients with N2 lung cancer were extrac...
Read more >>
|
|
|
I. Gin, I. Chistyakova, V. Zenin, S. Koshkin, A. Musorina, Y. Lahina, G. Timin, V. Pospelov, S. Prikhodko, A. Petukhov, E. Tolkunova Views - 76 (Abstract) Abstract:Gliomas are solid brain tumors composed of tumor cells and recruited heterogenic stromal components. The study of the interactions between the perivascular niche and its surrounding cells is of great value in unraveling mechanisms of drug resistance in malignant gliomas. In this study, we isolated t...
Read more >>
|
|
|
U. Rilwan, A. Hudu, A. Ubaidullah, A. U. Maisalatee, A. A. Bello, E. I. Ugwu, G. O. Okara Views - 11 (Abstract) Abstract: A survey of Fertility Cancer and Hereditary Risks in Soil Sample of Nasarawa was carried out. This study assessed the level of Fertility Cancer and Hereditary Risks in some part of Nasarawa using the gamma-ray spectrometry. The mean concentration for 40 K was 645.29 ± 07...
Read more >>
|
|
|
Aditi Mittal, Kanu Neemawat, Sandeep Jasuja, Anushree Chaturvedi Views - 12 (Abstract) Abstract:Cancer is a leading cause of death for children and adolescent worldwide. The cure rates in low middle-income countries are dismal (20%) in comparison to high income countries (80%). The first move is to assemble precise data on epidemiology of pediatric cancer across the country and its region wide...
Read more >>
|
|
|
Lisiane Silveira Zavalhia, Andrea Pires Souto Damin, Grasiela Agnes, Aline Weber, Taís Frederes Kramer Alcalde, Laura Marinho Dorneles, Guilherme Watte, Adriana Vial Roehe Views - 6 (Abstract) Abstract: The loss of heterozygosity (LOH) is a genetic event that can change gene function. FHIT is a potential tumor suppressor gene. Although the precise FHIT molecular mechanism of action is not well understood, evidences suggest that Fhit protein reduced levels are involved in mammary carcin...
Read more >>
|
|
|
Alexander Aizikovich Views - 19 (Abstract) Abstract:The in vitro study of tetracannabinolic acid (THCA) derivatives ALAM027 and ALAM108 was carried out on the following human tumor cells: T47D (breast, ductal carcinoma), PC-3 (prostate, adenocarcinoma), HT29 (colorectal carcinoma), Caco-2 (colon, adenocarcinoma), A549 (lung, carcinoma), U87MG (human ...
Read more >>
|
|
|
Daniela Kristina D. Carolino, Edwin Joseph R. Guerzon, Richard S. Rotor Views - 10 (Abstract) Abstract:Giant cell tumor of the bone (GCTB) is a benign, locally aggressive neoplasm that is relatively rare, with a propensity to result in progressive bone destruction, and is associated with a high risk of recurrence. There is no widely held consensus regarding its ideal treatment. Worldwide, there are v...
Read more >>
|
|
Reviews
|
Avik Mandal Views - 14 (Abstract) Abstract: Pancreatic adenocarcinoma (PAC) is an extremely fatal malignancy with dismal outcome with standard treatment till date. Investigators are constantly in search of optimal treatment approach and radiation therapy (RT) remains in the centre of debate. Human pancreatic cancer cell lines have shown bo...
Read more >>
|
|
|
Tomas Koltai Views - 15 (Abstract) Abstract: Dose is one of the parameters that any pharmacologist seriously considers when studying the effects of a drug. If the necessary dose to achieve a desired pharmacological effect is in a toxic or very toxic range for human use, the drug will probably fall out from further research. The concentratio...
Read more >>
|
|
Announcements
Call for papers for VOL.3 ISSUE 1! |
|
We are collecting articles for the next issue of the journal. Interested scholars can contact me by email. Looking forward to cooperating with you in the future ! Email:jor@bilpublishing.com |
|
| Posted: November 18,2020 | |
| More Announcements... |